Trailhead Biosystems

Trailhead Biosystems raises $20M to enhance its iPSC-derived research portfolio

11th May, 2025

Chris Davis

Writer

Trailhead Biosystems raises $20M to enhance its iPSC-derived research portfolio

What does Trailhead Biosystems do?

Trailhead Biosystems is a biotechnology company based in Beachwood, OH that leverages an informatics-based approach for the precise differentiation of induced pluripotent stem cells (iPSCs) into functional human cell types, supporting advancements in drug discovery and regenerative medicine.

How much did they raise?

The company secured $20M in a funding round with undisclosed backers and no specified lead investor. The round is categorized as series unknown.

What are their plans for the money?

The funds will be used to expand its portfolio of iPSC-derived cells, enhancing preclinical drug discovery and disease modeling, which could accelerate the development of novel therapies and improve outcomes in regenerative medicine.

What have they achieved so far?

Trailhead Biosystems has demonstrated progress by launching its TrailBio® Vascular Leptomeningeal Cells (VLMCs) for blood-brain barrier research, addressing a critical need in neuroscience and drug delivery.

Key Contacts

Jan Jensen
CEO

Company Links

Looking for startup leads?

Every week we source, enrich and send you leads of decision makers from recently funded startups. Sent to you every Monday.

Learn more

Newsletter

Get a daily roundup of recently funded startups.

Recently raised

The latest funding rounds from our newsroom